SPIRIT OF MUMBAI

Hyderabad, India — SAI Parenteral's Limited (SPL), a diversified pharmaceutical formulation company, today announced the acquisition of a 74.6% controlling stake in Noumed Pharmaceuticals Pty Ltd, an Adelaide-based pharmaceutical company, for an aggregate sum of INR 125 crore. SAI Parenterals has also filed its IPO DRHP with SEBI in September 30, 2025 - the offer, with a face value of Rs 5 per equity share, comprises a fresh issue of up to Rs 285 crore and an offer for sale of up to 3,500,000 equity shares by existing shareholders. Noumed Pharmaceuticals, a company with AUD 60 million in revenue, is a supplier of private label over the counter (OTC) products to pharmacy chains across Australia and New Zealand. The company is currently establishing a state-of-the-art manufacturing facility in Adelaide with an investment of AUD 53 million. The facility is expected to begin commercial operations by the fourth quarter of CY 2026. With a strong portfolio of over 451 product dossiers, No...

The IPO is complete fresh issue aggregating to ₹ 2,900 million Madhuri Madhusudan Kela, wife of ace investor Madhusudan Kela, has a 5.6% stake in the company New Delhi–based MV Electrosystems has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for its proposed Initial Public Offering (IPO). The offer, with a face value of Rs 5 per equity share, consists of a fresh issue of up to ₹ 2,900 million. Madhuri Madhusudan Kela, wife of well-known investor Madhusudan Kela, has 11,50,000 shares or 5.6% stake in the company as on the date of the Draft Red Herring Prospectus. The proceeds from its fresh issue worth ₹1800 million will be for funding long-term working capital requirements of the company, ₹ 210 million for investment in research, design and development activities for new power electronic equipment, and general corporate purposes. The issue is being made through the book-building process, in line with SEBI ICDR Regulations, with up ...

December 1, 2025 - Mumbai   Shri Sanjay Jaju, Secretary, Ministry of Information and Broadcasting (I&B), Government of India, championed industry-led growth at the 12th Big Picture Summit, where CII unveiled a White Paper on Priority Policy Reforms to propel Indian M&E to new heights. The event also featured an Investor Meet with Waves Bazaar and a special homage video honoring industry legends who left us in 2025.   Mumbai, December 1: Artificial Intelligence (AI) is poised to be a transformational force for India’s Media and Entertainment (M&E) sector, observed Shri Sanjay Jaju, Secretary, Ministry of Information and Broadcasting (I&B), Government of India. Speaking at the inaugural session in Mumbai, Shri Jaju called on the industry to view the WAVES Summit not as a standalone event, but as part of an ongoing movement—one that continually inspires new waves of creativity, innovation, and progress.   “The WAVES Summit is much more than an event; it is a ...

Mumbai, December 1   The major recommendations in this White Paper, titled “Reimagining India’s M&E Sector: A Call for Action to Build a Future-Ready, Globally Competitive Industry by 2030,” represent not just a policy wish-list, but a blueprint for action—calling for unified regulation, digital-first innovation, robust infrastructure, industry-aligned skills, and world-class IP protection.   The Confederation of Indian Industry (CII) has unveiled its landmark White Paper, “Reimagining India’s M&E Sector: A Call for Action to Build a Future-Ready, Globally Competitive Industry by 2030,” outlining a bold vision and actionable roadmap for transforming India’s Media & Entertainment (M&E) sector. The White Paper was officially released on December 1, 2025, at the 12th CII Big Picture Summit, held over two days—December 1 and 2—in Mumbai.   This year’s summit, themed “The AI Era – Bridging Creativity and Commerce,” convened leading figures from government, indu...

 Artist Viveek Sharma presents Sacred Gestures, honoring feminine strength and grace through richly detailed canvases If you’re exploring Mumbai’s cultural circuit this weekend, make space for Viveek Sharma’s SACRED GESTURES—a compelling exhibition that transforms traditional and contemporary ideas of femininity into immersive visual experiences. Known for his dramatic light, saturated pigments and meticulous detailing, Sharma bridges the real and the imagined through canvases inspired by Lavani traditions, divine feminine archetypes and iconic figures from popular culture. The exhibition is to be inaugurated on 2nd December at 6:30 PM by Shobhaa De (author, columnist, novelist) and Rashmin Majithia (Founder, Zen Crafart), setting the tone for a showcase that celebrates strength, grace, passion and transformation. Thought-provoking and visually rich, it stands out as one of the week’s most compelling art events. Dates: 3–8 December, 11 AM–7 PM Venue: Jehangir Art Gallery, Kala Ghod...

  Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally New center will help improve safety, efficacy, and quality in biopharma development Combination of Cytiva's analytical technologies with Veeda's extensive service delivery capabilities and regulatory expertise     November 28, 2025:  Cytiva, a Danaher company and a leader in the life sciences industry, is collaborating with Veeda Lifesciences (Veeda Clinical Research Limited), a global contract research organization, to establish a dedicated Host Cell Protein (HCP) Services Center in Bengaluru, India. Focused on impurity analysis and HCP testing, this new center will help biopharmaceutical companies reduce development risks and meet regulatory standards for novel biologics and biosimilars.   Dr. Mahesh Bhalgat, Group CEO and Managing Director, Veeda Lifesciences (Veeda Clinical Research Limited...